Cryptococcus neoformans is a leading cause of central nervous system infections in AIDS patients, and fully satisfactory methods for treating and preventing these infections are not yet available. We have shown that C. neoformans produces large amounts of the hexitol D-mannitol in culture and in infected animals. Although the functions of D-mannitol in C. neoformans are not yet known, the substantial amounts of energy and nutritional resources expended on D-mannitol biosynthesis suggest that D- mannitol if functionally important. As well, other fungi utilize D- mannitol and other polyols for storing energy and reducing equivalents and for regulating intracellular tonicity, pH and NADPH levels. The D-mannitol produced within infected tissues by C. neoformans may also contribute more directly to pathogenesis by causing brain edema (a characteristic of cryptococcal meningitis) or by scavenging free hydroxyl radicals (thus interfering with oxidative killing by host phagocytes). Since D-mannitol is not a produce of mammalian metabolism, the enzymes that catalyze D- mannitol metabolism in C. neoformans are potential therapeutic targets. The overall goal of this project is to conduct basic studies of D-mannitol metabolism in C. neoformans, especially as it relates to pathogenesis and to possible future therapies.
Specific Aim 1 is to identify, purify and characterize the enzymes that catalyze D-mannitol biosynthesis and catabolism in C. neoformans.
Specific Aim 2 is to sequence and analyze the gene that encodes the NAD-dependent D-mannitol dehydrogenase (NAD-MDH or MPD will be constructed by gene disruption and replacement, and mutants unable to utilize and/or produce D-mannitol will be generated by classical mutagenesis and selection.
In Aim 5, mutants obtained in Aim 4 will be characterized phenotypically and enzymatically. In addition, we will study the abilities of these mutants i) to resist killing by host phagocytes and their oxidative products and ii) to cause brain edema and/or death in experimentally-infected animals.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Dohn, M N; White, M L; Vigdorth, E M et al. (2000) Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection. Am J Respir Crit Care Med 162:1617-21
Javaid, Z Z; el Kouni, M H; Iltzsch, M H (1999) Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from Toxoplasma gondii. Biochem Pharmacol 58:1457-65
De Stefano, J A; Myers, J D; Du Pont, D et al. (1998) Cell wall antigens of Pneumocystis carinii trophozoites and cysts: purification and carbohydrate analysis of these glycoproteins. J Eukaryot Microbiol 45:334-43
Flynn, T M; Niehaus, W G (1997) Improved method for isolation of DNA from slow-growing basidiomycetes such as Armillaria mellea. Biotechniques 22:47, 50-2
Beach, D H; Chen, F; Cushion, M T et al. (1997) Effects of steroidal allenic phosphonic acid derivatives on the parasitic protists Leishmania donovani, Leishmania mexicana mexicana, and Pneumocystis carinii carinii. Antimicrob Agents Chemother 41:162-8
Theus, S A; Andrews, R P; Linke, M J et al. (1997) Characterization of rat CD4 T cell clones specific for the major surface glycoprotein of Pneumocystis carinii. J Eukaryot Microbiol 44:96-100
Chaturvedi, V; Flynn, T; Niehaus, W G et al. (1996) Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. Microbiology 142 ( Pt 4):937-43
Niehaus, W G; Richardson, S B; Wolz, R L (1996) Slow-binding inhibition of 6-phosphogluconate dehydrogenase by zinc ion. Arch Biochem Biophys 333:333-7
Chaturvedi, V; Wong, B; Newman, S L (1996) Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 156:3836-40
Ellis, J E; Wyder, M A; Zhou, L et al. (1996) Composition of Pneumocystis carinii neutral lipids and identification of coenzyme Q10 as the major ubiquinone homolog. J Eukaryot Microbiol 43:165-70

Showing the most recent 10 out of 39 publications